Influence of propofol on erythrocyte morphology, blood viscosity and platelet function

Clinical Hemorheology and Microcirculation

Volumn 29, Issue 1, 2003, Pages 33-40

  Reinhart, W H ^a   Felix, Ch ^a  

^a KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

Author keywords

Blood viscosity; Erythrocytes; Platelet aggregation; Propofol

Indexed keywords

ADRENALIN; PROPOFOL;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BLOOD VISCOSITY; CARDIOVASCULAR SYMPTOM; CELL TRANSFORMATION; CONTROLLED STUDY; DOSE RESPONSE; ECHINOCYTE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE SHAPE; ERYTHROCYTE STRUCTURE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INTERCALATION COMPLEX; NORMAL HUMAN; PLASMA VISCOSITY; SHEAR RATE; TARGET CELL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADULT; ANESTHETICS, INTRAVENOUS; BLOOD PLATELETS; BLOOD VISCOSITY; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; PLATELET AGGREGATION; PROPOFOL;

EID: 0242297814     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. E. Alhanaty and M.P. Sheetz, Control of the erythrocyte membrane shape: recovery from the effect of crenating agents, J. Cell. Biol. 91 (1981), 884-888.
2. H. Aoki, T. Mizobe, S. Nozuchi and N. Hiramatsu, In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation, Anesthesiology 88 (1998), 362-370.
3. M. Bessis, Red cell shapes. An illustrated classification and its rationales, Nouv. Rev. Franc. Hématol. 12 (1972), 721-746.
4. F. Boer, P. Ros, J.G. Bovill et al., Effect of propofol on peripheral vascular resistance during cardiopulmonary bypass, Br. J. Anaesth. 65 (1990), 184-189.
5. S. Chien, Biophysical behaviour of red cells in suspension, in: The Red Blood Cell, D. MacN Surgenor, ed., Academic Press, New York, 1975, pp. 1031-1133.
6. O.L. Cremer, K.G.M. Moons, E.A.C. Bouman et al., Long-term propofol infusion and cardiac failure in adult head-injured patients, Lancet 357 (2001), 117-118.
7. J.P. De La Cruz, J.A. Carmona, M.V. Paez et al., Propofol inhibits in vitro platelet aggregation in human whole blood, Anesth. Analg. 84 (1997), 919-921.
8. J.P. De La Cruz, M.V. Páez, J.A. Carmona and F. Sanchez De La Cuesta, Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leukocytes, Br. J. Pharmacol. 128 (1999), 1538-1544.
9. I.V. Doǧan, E. Ovali, Z. Eti et al., The in vitro effects of isoflurane, sevoflurane, and propofol on platelet aggregation, Anesth. Analg. 88 (1999), 432-436.
10. C. Escudero, M. Santos, J. Buján et al., Optical aggregometry versus the PFA-100™: experimental studies in pigs treated with propofol, Platelets 12 (2001), 133-137.
11. J.E. Ferrell, Jr. and W.H. Huestis, Phosphoinositide metabolism and the morphology of human erythrocyte, J. Cell. Biol. 98 (1984), 1992-1998.
12. L. Gramstad and J. Stovner, Plasma viscosity and cremophor-containing anaesthetics, Br. J. Anaesth. 51 (1979), 1175-1179.
13. Guidelines for measurement of blood viscosity and erythrocyte deformability. International Committee for Standardization in Haematology. Expert panel on blood rheology, Clin. Hemorheol. 6 (1986), 439-453.
14. N. Hezard, D. Metz, P. Nazeyrollas et al., Use of the PFA-100 apparatus to assess platelet function in patients undergoing PTCA during and after infusion of c7E3 Fab in the presence of other antiplatelet agents, Thromb. Haemost. 83 (2000), 540-544.
15. H. Hirakata, K. Nakamura, B. Yokubol et al., Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro, Anesthesiology 91 (1999), 1361-1369.
16. S.K. Kundu, E.J. Heilmann, R. Sio et al., Description of an in vitro platelet function analyzer - PFA-100, Semin. Thromb. Hemost. 21(Suppl. 2) (1995), 106-112.
17. M. Mark, R. Walter, D.O. Meredith and W.H. Reinhart, Commercial taxane formulations induce stomatocytosis and increase blood viscosity, Br. J. Pharmacol. 134 (2001), 1207-1214.
18. A. Masuda, K. Hirota, T. Satone and Y. Ito, Pink urine during propofol anesthesia, Anesth. Analg. 83 (1996), 666-667.
19. F.C. Mokken, C.P. Henny, A.W. Gelb et al., The effects of propofol compared to high-dose fentanyl anesthesia on rheologic parameters in coronary artery surgery, J. Cardiothorac. Vasc. Anesth. 7 (1993), 10-16.
20. K. Nandate, A. Vuylsteke, I. Ratsep et al., Effects of isoflurane, sevoflurane and propofol anaesthesia on jugular venous oxygen saturation in patients undergoing coronary artery bypass surgery, Br. J. Anaesth. 84 (2000), 631-633.
21. J.E. Orr, R.J.L. Davidson, I.F. Russell and G.S. Robertson, A haemorheological study of althesin, Br. J. Anaesth. 54 (1982), 1003-1006.
22. T.L. Ortel, A.H. James, E.H. Thames et al., Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center, Thromb. Haemost. 84 (2000), 93-97.
23. W.H. Reinhart, G.M. Baerlocher, T. Cerny et al., Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood, Eur. J. Haematol. 62 (1999), 223-230.
24. M.P. Sheetz and S.J. Singer, Equilibrium and kinetic effects of drugs on the shape of human erythrocytes, J. Cell. Biol. 70 (1976), 247-251.
25. H. Türkan, A.H. Süer, C. Beyan and A. Yalçin, Propofol does not affect platelet aggregation, Eur. J. Anaesthesiol. 13 (1996), 408-409.